Lombard Odier Asset Management (USA)’s GenMark Diagnostics, Inc GNMK Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-42,920	Closed	-$206K	–	282
2019 Q4	$206K	Buy	42,920 +7,920	+23%	+$43.7K	0.02%	220
2019 Q3	$212K	Sell	35,000 -7,920	-18%	-$49.4K	0.02%	237
2019 Q2	$279K	Hold	42,920	–	–	0.02%	205
2019 Q1	$304K	Hold	42,920	–	–	0.03%	214
2018 Q4	$209K	Buy	42,920 +7,920	+23%	+$41.2K	0.02%	219
2018 Q3	$257K	Hold	35,000	–	–	0.02%	217
2018 Q2	$223K	Buy	+35,000	New	+$231K	0.01%	250

Other funds holding GNMK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s GNMK Position: Q1 2020 in Review

Lombard Odier Asset Management (USA) sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2020, closing a stake of 42,920 shares — an estimated $206K sold.

Lombard Odier Asset Management (USA) first reported a position in GNMK in Q2 2018 and held it in 7 quarters. The position peaked at $304K in Q1 2019. 110 funds tracked by Wall St. Rank hold GNMK as of Q1 2020.

Lombard Odier Asset Management (USA) reported no remaining GenMark Diagnostics, Inc position as of Q1 2020 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 42,920 GenMark Diagnostics, Inc shares in Q1 2020, an estimated $206K.
Lombard Odier Asset Management (USA) first reported a position in GenMark Diagnostics, Inc in Q2 2018 and held it in 7 quarters.
Lombard Odier Asset Management (USA)'s GenMark Diagnostics, Inc position peaked at $304K in Q1 2019.
110 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2020.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q1 2020, filed 15 May 2020.